EP 4096629 A1 20221207 - BUTYRIC ACID SALT-BASED COMPOSITION FOR RECTAL APPLICATION FOR THE TREATMENT OF PROCTOLOGY DISORDERS
Title (en)
BUTYRIC ACID SALT-BASED COMPOSITION FOR RECTAL APPLICATION FOR THE TREATMENT OF PROCTOLOGY DISORDERS
Title (de)
AUF BUTTERSÄURESALZ BASIERENDE ZUSAMMENSETZUNG ZUR REKTALEN ANWENDUNG ZUR BEHANDLUNG VON PROCTOLOGIESTÖRUNGEN
Title (fr)
COMPOSITION À BASE DE SEL D'ACIDE BUTYRIQUE POUR APPLICATION RECTALE POUR LE TRAITEMENT DE TROUBLES PROCTOLOGIQUES
Publication
Application
Priority
- IT 202000001831 A 20200130
- IB 2021050659 W 20210128
Abstract (en)
[origin: WO2021152492A1] A water-based composition for use in the rectal treatment of proctological disorders comprising sodium hyaluronate butyrate and a polymer compound belonging to the polysiloxane family and having a nominal viscosity ranging from 200 to 500 mm2/s. The weight ratio between sodium hyaluronate butyrate and the polymer compound ranges from 0.01 to 0.1.
IPC 8 full level
A61K 9/00 (2006.01); A61K 9/107 (2006.01); A61K 31/728 (2006.01); A61K 47/34 (2017.01); A61P 9/14 (2006.01)
CPC (source: EP)
A61K 9/0031 (2013.01); A61K 9/107 (2013.01); A61K 31/728 (2013.01); A61K 47/34 (2013.01); A61P 9/14 (2018.01)
Citation (examination)
- EP 2442771 B1 20200205 - ADVANCED BIO TECH INC [US]
- EP 0731705 B1 20011107 - SCHMIDT ALFRED [DE], et al
- See also references of WO 2021152492A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
WO 2021152492 A1 20210805; EP 4096629 A1 20221207; IT 202000001831 A1 20210730
DOCDB simple family (application)
IB 2021050659 W 20210128; EP 21708364 A 20210128; IT 202000001831 A 20200130